Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000132378 | SCV000187469 | uncertain significance | Hereditary cancer-predisposing syndrome | 2017-11-20 | criteria provided, single submitter | clinical testing | Insufficient or conflicting evidence |
Invitae | RCV000542816 | SCV000625420 | uncertain significance | Hereditary nonpolyposis colorectal neoplasms | 2017-10-03 | criteria provided, single submitter | clinical testing | This sequence change falls in intron 2 of the MSH2 gene. It does not directly change the encoded amino acid sequence of the MSH2 protein. This variant is not present in population databases (ExAC no frequency) and has not been reported in the literature in individuals with an MSH2-related disease. ClinVar contains an entry for this variant (Variation ID: 142907). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may alter RNA splicing, but this prediction has not been confirmed by published transcriptional studies. In summary, this is a rare intronic change with uncertain impact on splicing. It has been classified as a Variant of Uncertain Significance. |